Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities

April 25, 2024 5:05 PM
(Updated - April 25, 2024 5:05 PM EDT)

Truist Securities analyst Robyn Karnauskas lowered the price target on Bristol-Myers ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles